Using Oncology Patient Monitoring Data To Improve Outcomes

Through a grant from the National Cancer Institute (NCI), Charles River Analytics is building a platform to collect and analyze biometric sensor data and connected devices used by cancer patients across the US. The goal of the project is to support large-scale population health research and to improve cancer outcomes.

digital monitoring

Patient monitoring data is collected constantly, by patients’ smart phones and watches, fitness trackers and apps, and connected devices such as blood pressure monitors, scales or smart pill bottles. Unfortunately, these data are largely not aggregated or assembled for clinical research, outside of individual studies. As a result, the true value of such data is largely unknown; at the very least, it is a missed opportunity.

Oncology research has shed new light on the ever-expanding variations of cancer, even within the same subtypes. The National...

More from Innovation

More from In Vivo

Deals In Depth: June 2025

 
• By 

Five $1bn+ alliances were penned in June, and four exceeded $2bn.

Global Pharma Interest In Korea Undeterred Despite Political Roller Coaster

 
• By 

Despite recent political turmoil, outside investor and corporate interest in South Korean biopharma innovation appears robust or even increasing.

Podcast: Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

 
• By 

Agnès Arbat, CEO of Oxolife and winner of the EU Women Innovators Prize, joins In Vivo to discuss OXO-001, a novel non-hormonal treatment aimed at improving embryo implantation in IVF. She shares insights from her biotech journey and the future of fertility innovation.